{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:18:29Z","timestamp":1791191909157,"version":"4.1.0"},"reference-count":109,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.ijcard.2016.10.069","type":"journal-article","created":{"date-parts":[[2016,10,27]],"date-time":"2016-10-27T21:03:56Z","timestamp":1477602236000},"page":"734-742","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"special_numbering":"C","title":["New and old roles of the peripheral and brain renin\u2013angiotensin\u2013aldosterone system (RAAS): Focus on cardiovascular and neurological diseases"],"prefix":"10.1016","volume":"227","author":[{"given":"A","family":"Mascolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Sessa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Scavone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"De Angelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Vitale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Berrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Rosano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Capuano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 3","key":"10.1016\/j.ijcard.2016.10.069_bb0005","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/00005344-199000153-00001","article-title":"The renin\u2013angiotensin system: importance in physiology and pathology","volume":"15","author":"Ferrario","year":"1990","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0010","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ijcard.2016.03.080","article-title":"The pathophysiological role of natriuretic peptide-RAAS cross talk in heart failure","volume":"226","author":"Rossi","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0015","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00109-008-0331-5","article-title":"Brain renin angiotensin in disease","volume":"86","author":"Phillips","year":"2008","journal-title":"J. Mol. Med. (Berl)."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0020","first-page":"67","article-title":"Brain renin\u2013angiotensin system and dopaminergic cell vulnerability","volume":"8","author":"Labandeira-Garc\u00eda","year":"2014","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0025","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijcard.2016.03.085","article-title":"Modulation of RAAS-natriuretic peptides in the treatment of HF: old guys and newcomers","volume":"226","author":"Mollace","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0030","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/nrendo.2015.6","article-title":"Novel RAAS agonists and antagonists: clinical applications and controversies","volume":"11","author":"Romero","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0035","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1038\/sj.ki.5000265","article-title":"Renin\/prorenin receptors","volume":"69","author":"Nguyen","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0040","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1161\/01.RES.0000251700.00994.0d","article-title":"A novel signal transduction cascade involving direct physical interaction of the renin\/prorenin receptor with the transcription factor promyelocytic zinc finger protein","volume":"99","author":"Schefe","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0045","doi-asserted-by":"crossref","first-page":"3A","DOI":"10.1016\/S0002-9149(01)02321-9","article-title":"The role of the renin\u2013angiotensin system in the development of cardiovascular disease","volume":"89","author":"Unger","year":"2002","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0050","article-title":"Aldosterone synthase inhibitors in hypertension: current status and future possibilities","volume":"3","author":"Hargovan","year":"2014","journal-title":"JRSM Cardiovasc. Dis."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0055","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0006-291X(05)80157-3","article-title":"Identification and characterization of a new binding site for angiotensin II in mouse neuroblastoma neuro-2A cells","volume":"182","author":"Chaki","year":"1992","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0060","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s12020-010-9328-2","article-title":"Preliminary biochemical characterization of the novel, non-AT1, non-AT2 angiotensin binding site from the rat brain","volume":"37","author":"Karamyan","year":"2010","journal-title":"Endocrine"},{"key":"10.1016\/j.ijcard.2016.10.069_bb0065","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1161\/HYPERTENSIONAHA.109.140145","article-title":"Therapeutic implications of the vasoprotective axis of the renin\u2013angiotensin system in cardiovascular diseases","volume":"55","author":"Ferreira","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2016.10.069_bb0070","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2119\/2007-00073.Fraga-Silva","article-title":"The antithrombotic effect of angiotensin-(1\u20137) involves mas-mediated NO release from platelets","volume":"14","author":"Fraga-Silva","year":"2008","journal-title":"Mol. Med."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0075","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1161\/HYPERTENSIONAHA.108.114280","article-title":"Molecular mechanisms involved in the angiotensin-(1\u20137)\/Mas signaling pathway in cardiomyocytes","volume":"52","author":"Dias-Peixoto","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2016.10.069_bb0080","doi-asserted-by":"crossref","first-page":"5569","DOI":"10.4049\/jimmunol.1000314","article-title":"Anti-inflammatory effects of the activation of the angiotensin-(1\u20137) receptor, MAS, in experimental models of arthritis","volume":"185","author":"da Silveira","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0085","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3389\/fendo.2013.00201","article-title":"Update on the angiotensin converting enzyme 2-angiotensin (1\u20137)-MAS receptor axis: fetal programing, sex differences, and intracellular pathways","volume":"4","author":"Chappell","year":"2014","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.ijcard.2016.10.069_bb0090","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.pharmthera.2014.05.002","article-title":"Current role of neprilysin inhibitors in hypertension and heart failure","volume":"144","author":"von Lueder","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0095","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1042\/CS20130396","article-title":"A new strategy for treating hypertension by blocking the activity of the brain renin\u2013angiotensin system with aminopeptidase A inhibitors","volume":"127","author":"Gao","year":"2014","journal-title":"Clin. Sci."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0100","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1007\/s00018-004-4246-1","article-title":"The angiotensin IV\/AT4 receptor","volume":"61","author":"Chai","year":"2004","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0105","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0031-6997(25)06807-3","article-title":"Peptidergic modulation of learning and memory processes","volume":"46","author":"Kov\u00e1cs","year":"1994","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0110","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2174\/1389203043379341","article-title":"The physiology of learning and memory: role of peptides and stress","volume":"5","author":"G\u00fclpinar","year":"2004","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0115","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1523\/JNEUROSCI.5295-09.2010","article-title":"Somatostatin signaling in neuronal cilia is critical for object recognition memory","volume":"30","author":"Einstein","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0120","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1093\/eurheartj\/ehr253","article-title":"Therapeutic perspectives in hypertension: novel means for renin\u2013angiotensin\u2013aldosterone system modulation and emerging device-based approaches","volume":"32","author":"Unger","year":"2011","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0125","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1161\/CIRCULATIONAHA.110.955369","article-title":"Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction","volume":"122","author":"Zhong","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.10.069_bb0130","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2337\/db09-1218","article-title":"Human recombinant ACE2 reduces the progression of diabetic nephropathy","volume":"59","author":"Oudit","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.ijcard.2016.10.069_bb0135","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s40262-013-0072-7","article-title":"Pharmacokinetics and pharmacodynamics of recombinant human angiotensin-converting enzyme 2 in healthy human subjects","volume":"52","author":"Haschke","year":"2013","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0140","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s11010-012-1489-2","article-title":"Effect of combination of renin inhibitor and Mas-receptor agonist in DOCA-salt-induced hypertension in rats","volume":"373","author":"Singh","year":"2013","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0145","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.peptides.2013.11.006","article-title":"An orally active angiotensin-(1\u20137) inclusion compound and exercise training produce similar cardiovascular effects in spontaneously hypertensive rats","volume":"51","author":"Bertagnolli","year":"2014","journal-title":"Peptides"},{"key":"10.1016\/j.ijcard.2016.10.069_bb0150","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1111\/j.1476-5381.2012.01905.x","article-title":"Angiotensin-(1\u20137) inhibits allergic inflammation, via the MAS1 receptor, through suppression of ERK1\/2- and NF-\u03baB-dependent pathways","volume":"166","author":"El-Hashim","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0155","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1161\/HYPERTENSIONAHA.111.180158","article-title":"Angiotensin type 2 receptor agonist compound 21 reduces vascular injury and myocardial fibrosis in stroke-prone spontaneously hypertensive rats","volume":"59","author":"Rehman","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2016.10.069_bb0160","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1161\/HYPERTENSIONAHA.111.185496","article-title":"Direct angiotensin II type 2 receptor stimulation in N\u03c9-nitro-l-arginine-methyl ester-induced hypertension: the effect on pulse wave velocity and aortic remodeling","volume":"59","author":"Paulis","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2016.10.069_bb0165","doi-asserted-by":"crossref","first-page":"F1379","DOI":"10.1152\/ajprenal.00002.2015","article-title":"Angiotensin AT2 receptor agonist prevents salt-sensitive hypertension in obese Zucker rats","volume":"308","author":"Ali","year":"2015","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0170","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/FJC.0000000000000207","article-title":"A nonpeptide angiotensin II type 2 receptor agonist prevents renal inflammation in early diabetes","volume":"65","author":"Matavelli","year":"2015","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0175","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ijcard.2015.07.038","article-title":"Mineralocorticoid receptor antagonists in heart failure with preserved ejection fraction (HFpEF)","volume":"200","author":"Capuano","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0180","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1093\/eurheartj\/eht187","article-title":"Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial","volume":"34","author":"Pitt","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0185","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/FJC.0b013e3182495543","article-title":"SM-368229, a novel promising mineralocorticoid receptor antagonist, shows antihypertensive efficacy with minimal effect on serum potassium level in rats","volume":"59","author":"Nariai","year":"2012","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0190","doi-asserted-by":"crossref","first-page":"29932","DOI":"10.1074\/jbc.M110.131342","article-title":"A new mode of mineralocorticoid receptor antagonism by a potent and selective nonsteroidal molecule","volume":"285","author":"Fagart","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0195","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/MNH.0000000000000147","article-title":"Nonsteroidal antagonists of the mineralocorticoid receptor","volume":"24","author":"Kolkhof","year":"2015","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0200","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.bmcl.2010.11.040","article-title":"N-(Pyridin-3-yl)benzamides as selective inhibitors of human aldosterone synthase (CYP11B2)","volume":"21","author":"Zimmer","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0205","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ijcard.2009.03.032","article-title":"Vaccine for hypertension: modulating the renin\u2013angiotensin system","volume":"134","author":"Pandey","year":"2009","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0210","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0140-6736(08)60381-5","article-title":"Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: a double-blind, randomised, placebo-controlled phase IIa study","volume":"371","author":"Tissot","year":"2008","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ijcard.2016.10.069_bb0215","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin\u2013neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0220","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1161\/01.HYP.35.1.409","article-title":"The brain renin\u2013angiotensin system modulates angiotensin II-induced hypertension and cardiac hypertrophy","volume":"35","author":"Baltatu","year":"2000","journal-title":"Hypertension"},{"issue":"Suppl 1","key":"10.1016\/j.ijcard.2016.10.069_bb0225","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.3317\/jraas.2002.029","article-title":"Organisation and functional role of the brain angiotensin system","volume":"3","author":"Llorens-Cortes","year":"2002","journal-title":"J. Renin-Angiotensin-Aldosterone Syst."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0230","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1152\/japplphysiol.00569.2012","article-title":"The brain renin\u2013angiotensin system and cardiovascular responses to stress: insights from transgenic rats with low brain angiotensinogen","volume":"113","author":"Arnold","year":"2012","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0235","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s10571-006-9009-0","article-title":"Mechanisms of the anti-ischemic effect of angiotensin II AT(1) receptor antagonists in the brain","volume":"26","author":"Saavedra","year":"2006","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0240","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/0006-8993(76)90032-9","article-title":"Specific angiotensin II receptive neurons in the cat subfornical organ","volume":"109","author":"Phillips","year":"1976","journal-title":"Brain Res."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0245","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/270445a0","article-title":"Lowering of hypertension by central saralasin in the absence of plasma renin","volume":"270","author":"Phillips","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.ijcard.2016.10.069_bb0250","first-page":"S63","article-title":"Effect of central administration of MK-422 (the diacid form of enalapril) on the development of hypertension in the spontaneously hypertensive rat","volume":"2","author":"Berecek","year":"1984","journal-title":"J. Hypertens. Suppl."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0255","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0361-9230(01)00586-X","article-title":"Renin antisense injected intraventricularly decreases blood pressure in spontaneously hypertensive rats","volume":"56","author":"Kubo","year":"2001","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0260","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1046\/j.1440-1681.2001.03583.x","article-title":"Inhibitory effects of angiotensin II on barosensitive rostral ventrolateral medulla neurons of the rat","volume":"28","author":"Bertram","year":"2001","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0265","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1161\/01.HYP.15.3.284","article-title":"Baroreceptor reflex enhancement by chronic intracerebroventricular infusion of enalapril in normotensive rats","volume":"15","author":"Bunag","year":"1990","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2016.10.069_bb0270","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/apha.12207","article-title":"Nitric oxide impacts on angiotensin AT2 receptor modulation of high-pressure baroreflex control of renal sympathetic nerve activity in anaesthetized rats","volume":"210","author":"Abdulla","year":"2014","journal-title":"Acta Physiol. (Oxf)."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0275","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1161\/HYPERTENSIONAHA.111.190108","article-title":"Brain-targeted (pro)renin receptor knockdown attenuates angiotensin II-dependent hypertension","volume":"59","author":"Li","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2016.10.069_bb0280","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1161\/CIRCRESAHA.110.226977","article-title":"Involvement of the brain (pro)renin receptor in cardiovascular homeostasis","volume":"107","author":"Shan","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0285","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1161\/HYPERTENSIONAHA.114.04458","article-title":"Intracerebroventricular infusion of the (pro)renin receptor antagonist PRO20 attenuates deoxycorticosterone acetate-salt-induced hypertension","volume":"65","author":"Li","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2016.10.069_bb0290","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.brainres.2010.08.081","article-title":"AT\u2081 angiotensin II receptor and novel non-AT\u2081, non-AT\u2082 angiotensin II\/III binding site in brainstem cardiovascular regulatory centers of the spontaneously hypertensive rat","volume":"1359","author":"Bourassa","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0295","doi-asserted-by":"crossref","first-page":"H699","DOI":"10.1152\/ajpheart.00193.2013","article-title":"Central endogenous angiotensin-(1\u20137) protects against aldosterone\/NaCl-induced hypertension in female rats","volume":"305","author":"Xue","year":"2013","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0300","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1161\/HYPERTENSIONAHA.114.04691","article-title":"Brain-targeted angiotensin-converting enzyme 2 overexpression attenuates neurogenic hypertension by inhibiting cyclooxygenase-mediated inflammation","volume":"65","author":"Sriramula","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2016.10.069_bb0305","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1093\/ajh\/hpu066","article-title":"Actions of circulating angiotensin II and aldosterone in the brain contributing to hypertension","volume":"27","author":"Leenen","year":"2014","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0310","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1161\/HYPERTENSIONAHA.107.099796","article-title":"Does aldosterone upregulate the brain renin\u2013angiotensin system in rats with heart failure?","volume":"51","author":"Yu","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2016.10.069_bb0315","doi-asserted-by":"crossref","first-page":"H1067","DOI":"10.1152\/ajpheart.01131.2007","article-title":"Aldosterone acts centrally to increase brain renin\u2013angiotensin system activity and oxidative stress in normal rats","volume":"294","author":"Zhang","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0320","doi-asserted-by":"crossref","first-page":"474870","DOI":"10.1155\/2012\/474870","article-title":"Renin\u2013angiotensin system and sympathetic neurotransmitter release in the central nervous system of hypertension","volume":"2012","author":"Tsuda","year":"2012","journal-title":"Int. J. Hypertens."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0325","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1113\/expphysiol.2006.036830","article-title":"Brain superoxide as a key regulator of the cardiovascular response to emotional stress in rabbits","volume":"92","author":"Mayorov","year":"2007","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0330","doi-asserted-by":"crossref","first-page":"R799","DOI":"10.1152\/ajpregu.00566.2011","article-title":"Differences in oxidative stress status and expression of MKP-1 in dorsal medulla of transgenic rats with altered brain renin\u2013angiotensin system","volume":"303","author":"Nautiyal","year":"2012","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0335","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1440-1681.2009.05159.x","article-title":"Inhibition of brain renin\u2013angiotensin system improves diastolic cardiac function following myocardial infarction in rats","volume":"36","author":"Araujo","year":"2009","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0340","doi-asserted-by":"crossref","first-page":"R1526","DOI":"10.1152\/ajpregu.91040.2008","article-title":"Ischemia-induced brain damage is enhanced in human renin and angiotensinogen double-transgenic mice","volume":"297","author":"Chen","year":"2009","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0345","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1111\/j.1471-4159.2008.05723.x","article-title":"Angiotensin-converting enzyme 2 in the brain: properties and future directions","volume":"107","author":"Xia","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0350","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1097\/HJH.0b013e32833af3b2","article-title":"Brain angiotensin peptides regulate sympathetic tone and blood pressure","volume":"28","author":"Dupont","year":"2010","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0355","doi-asserted-by":"crossref","first-page":"H2138","DOI":"10.1152\/ajpheart.00112.2004","article-title":"Brain angiotensin-converting enzyme activity and autonomic regulation in heart failure","volume":"287","author":"Francis","year":"2004","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0360","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.yjmcc.2007.07.047","article-title":"Sympathetic hyperactivity and cardiac dysfunction post-MI: different impact of specific CNS versus general AT1 receptor blockade","volume":"43","author":"Huang","year":"2007","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0365","doi-asserted-by":"crossref","first-page":"H1448","DOI":"10.1152\/ajpheart.00462.2014","article-title":"Angiotensin II type 1 receptor expression in astrocytes is upregulated leading to increased mortality in mice with myocardial infarction-induced heart failure","volume":"307","author":"Isegawa","year":"2014","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0370","doi-asserted-by":"crossref","first-page":"I57","DOI":"10.1161\/01.HYP.11.2_Pt_2.I57","article-title":"Brain renin\u2013angiotensin. Central control of secretion of atrial natriuretic factor from the heart","volume":"11","author":"Itoh","year":"1988","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2016.10.069_bb0375","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1532-5415.2004.52178_7.x","article-title":"Angiotensin-converting enzyme inhibitors and incidence of Alzheimer's disease in Japan","volume":"52","author":"Ohrui","year":"2004","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0380","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1212\/01.WNL.0000140705.23869.E9","article-title":"Effects of brain-penetrating ACE inhibitors on Alzheimer disease progression","volume":"63","author":"Ohrui","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.ijcard.2016.10.069_bb0385","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.pnpbp.2012.12.009","article-title":"Inhibition of central angiotensin II enhances memory function and reduces oxidative stress status in rat hippocampus","volume":"43","author":"Bild","year":"2013","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ijcard.2016.10.069_bb0390","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S1474-4422(07)70077-7","article-title":"Is inhibition of the renin-angiotensin system a new treatment option for Alzheimer's disease?","volume":"6","author":"Kehoe","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0395","doi-asserted-by":"crossref","first-page":"16917","DOI":"10.3390\/ijms140816917","article-title":"ACE inhibition with captopril retards the development of signs of neurodegeneration in an animal model of Alzheimer's disease","volume":"14","author":"AbdAlla","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0400","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/HYPERTENSIONAHA.111.173534","article-title":"Attenuation of brain damage and cognitive impairment by direct renin inhibition in mice with chronic cerebral hypoperfusion","volume":"58","author":"Dong","year":"2011","journal-title":"Hypertension"},{"issue":"Suppl 2","key":"10.1016\/j.ijcard.2016.10.069_bb0405","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1186\/1471-2202-9-S2-S14","article-title":"Development of cognitive enhancers based on inhibition of insulin-regulated aminopeptidase","volume":"9","author":"Chai","year":"2008","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0410","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1460-9568.2008.06347.x","article-title":"The insulin-regulated aminopeptidase IRAP is colocalised with GLUT4 in the mouse hippocampus\u2014potential role in modulation of glucose uptake in neurones?","volume":"28","author":"Fernando","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0415","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.mce.2008.11.015","article-title":"From angiotensin IV binding site to AT4 receptor","volume":"302","author":"Vanderheyden","year":"2009","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0420","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.physbeh.2006.03.025","article-title":"D2 dopamine receptor blockade prevents cognitive effects of Ang IV and des-Phe6 Ang IV","volume":"88","author":"Braszko","year":"2006","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0425","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.euroneuro.2008.08.011","article-title":"Dopamine D4 receptor antagonist L745,870 abolishes cognitive effects of intracerebroventricular angiotensin IV and des-Phe(6)-Ang IV in rats","volume":"19","author":"Braszko","year":"2009","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0430","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S0028-3908(00)00188-X","article-title":"Potentiation of cholinergic transmission in the rat hippocampus by angiotensin IV and LVV-hemorphin-7","volume":"40","author":"Lee","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ijcard.2016.10.069_bb0435","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1016\/j.peptides.2010.08.023","article-title":"Intrahippocampal norleucine(1)-angiotensin IV mitigates scopolamine-induced spatial working memory deficits","volume":"31","author":"Olson","year":"2010","journal-title":"Peptides"},{"key":"10.1016\/j.ijcard.2016.10.069_bb0440","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.mcn.2005.03.012","article-title":"Angiotensin-(1\u20137) enhances LTP in the hippocampus through the G-protein-coupled receptor Mas","volume":"29","author":"Hellner","year":"2005","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0445","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1007\/s12035-015-9260-9","article-title":"Angiotensin-(1\u20137) is reduced and inversely correlates with tau hyperphosphorylation in animal models of Alzheimer's disease","volume":"53","author":"Jiang","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0450","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/mds.25614","article-title":"Dopamine\u2013angiotensin interactions in the basal ganglia and their relevance for Parkinson's disease","volume":"28","author":"Labandeira-Garcia","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0455","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.expneurol.2013.10.014","article-title":"The angiotensin converting enzyme inhibitor captopril protects nigrostriatal dopamine neurons in animal models of parkinsonism","volume":"250","author":"Sonsalla","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0460","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/ddr.20028","article-title":"The brain renin\u2013angiotensin system: a target for novel antidepressants and anxiolytics","volume":"65","author":"Gard","year":"2005","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0465","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.neuropharm.2015.12.026","article-title":"Increasing brain angiotensin converting enzyme 2 activity decreases anxiety-like behavior in male mice by activating central Mas receptors","volume":"105","author":"Wang","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ijcard.2016.10.069_bb0470","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.mehy.2012.11.043","article-title":"Angiotensin receptor blockers for bipolar disorder","volume":"80","author":"de Gois Queiroz","year":"2013","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.ijcard.2016.10.069_bb0475","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/syn.20868","article-title":"The AT\u2081 angiotensin II receptor blockade attenuates the development of amphetamine-induced behavioral sensitization in a two-injection protocol","volume":"65","author":"Paz","year":"2011","journal-title":"Synapse"},{"key":"10.1016\/j.ijcard.2016.10.069_bb0480","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2011.12.049","article-title":"Can bipolar disorder be viewed as a multi-system inflammatory disease?","volume":"141","author":"Leboyer","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0485","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jjcc.2012.08.004","article-title":"Telmisartan protects against cognitive decline via up-regulation of brain-derived neurotrophic factor\/tropomyosin-related kinase B in hippocampus of hypertensive rats","volume":"60","author":"Kishi","year":"2012","journal-title":"J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0490","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/0006-3223(89)90203-5","article-title":"Captopril treatment of major depression with serial measurements of blood cortisol concentrations","volume":"25","author":"Germain","year":"1989","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ijcard.2016.10.069_bb0495","first-page":"1","article-title":"Reduction of angiotensin II-induced drinking in rats by 21hour pretreatment with desipramine","volume":"43","author":"Gard","year":"1991","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0500","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0014-2999(94)00481-1","article-title":"Reduction of responses to angiotensin II by antidepressant drugs","volume":"264","author":"Gard","year":"1994","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0505","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1055\/s-0031-1291346","article-title":"Renin\u2013angiotensin\u2013aldosterone system: the forgotten stress hormone system: relationship to depression and sleep","volume":"45","author":"Murck","year":"2012","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.ijcard.2016.10.069_bb0510","doi-asserted-by":"crossref","first-page":"7775","DOI":"10.1073\/pnas.0402312101","article-title":"Brain renin\u2013angiotensin system blockade by systemically active aminopeptidase A inhibitors: a potential treatment of salt-dependent hypertension","volume":"101","author":"Fournie-Zaluski","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0515","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1161\/HYPERTENSIONAHA.112.190942","article-title":"Central antihypertensive effects of orally active aminopeptidase A inhibitors in spontaneously hypertensive rats","volume":"60","author":"Marc","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2016.10.069_bb0520","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/cvr\/cvs420","article-title":"Inhibition of brain angiotensin III attenuates sympathetic hyperactivity and cardiac dysfunction in rats post-myocardial infarction","volume":"97","author":"Huang","year":"2013","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0525","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s40262-013-0125-y","article-title":"Randomised, double-blind, placebo-controlled, dose-escalating phase I study of QGC001, a centrally acting aminopeptidase a inhibitor prodrug","volume":"53","author":"Balavoine","year":"2014","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0530","unstructured":"US National Library of Medicine. Clinicaltrials.gov [online], https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02322450?term=QGC001&rank=3, (2015)."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0535","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.pneurobio.2014.11.004","article-title":"The development of small molecule angiotensin IV analogs to treat Alzheimer's and Parkinson's diseases","volume":"125","author":"Wright","year":"2015","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0540","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1124\/jpet.111.182220","article-title":"Facilitation of hippocampal synaptogenesis and spatial memory by C-terminal truncated Nle1-angiotensin IV analogs","volume":"339","author":"Benoist","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ijcard.2016.10.069_bb0545","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1124\/jpet.112.199497","article-title":"Evaluation of metabolically stabilized angiotensin IV analogs as procognitive\/antidementia agents","volume":"344","author":"McCoy","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316332314?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316332314?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T22:02:34Z","timestamp":1749679354000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527316332314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":109,"alternative-id":["S0167527316332314"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.10.069","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New and old roles of the peripheral and brain renin\u2013angiotensin\u2013aldosterone system (RAAS): Focus on cardiovascular and neurological diseases","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.10.069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}